Phase II Clinical Trials in Oncology: Strengths and Limitations of Two-Stage Designs

By Schlesselman James   Reis Isildinha  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite

Ethical and Design Issues of Phase I Clinical Trials in Cancer Patients

By Grunwald Hans W.  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 124-126

Informa Healthcare

Access to resources Recommend Favorite

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

By Somlo G.   Martel C.   Lau S.   Frankel P.   Ruel C.   Gu L.   Hurria A.   Chung C.   Luu T.   Morgan R.   Leong L.   Koczywas M.   McNamara M.   Russell C.   Kane S.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with HPV16 Peptides of Patients with Advanced Cervical Carcinoma: Clinical Evaluation of a Phase I-II Trial

By van Driel W.J.   Ressing M.E.   Kenter G.G.   Brandt R.M.P.   Krul E.J.T.   van Rossum A.B.   Schuuring E.   Offringa R.   Bauknecht T.   Tamm-Hermelink A.   van Dam P.A.   Fleuren G.J.   Kast W.M.   Melief C.J.M.   Trimbos J.B.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 946-952

Elsevier

Access to resources Recommend Favorite